David Fallace
Listed on 3 Form D filings across 3+ issuers
· Director, Executive Officer
Associated issuers
- Crosslink Therapeutics Inc. CIK 2067583 · Massachusetts
- Cure Ventures Fund II, L.P. CIK 2094337 · Massachusetts
- Tasca Therapeutics Corp CIK 2046762 · Massachusetts
Filings (3)
-
Crosslink Therapeutics Inc.D · Oct 20, 2026 · Massachusetts · Pharmaceuticals$5.5MView filing →
-
Cure Ventures Fund II, L.P.D · Dec 18, 2025 · Massachusetts · Pooled Investment Fund
-
Tasca Therapeutics CorpD/A · Dec 1, 2025 · Massachusetts · Biotechnology$70.2MView filing →